A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma

Cell Death and Disease

Volumn 5, Issue 12, 2014, Pages

  Tang, J ^a   Zhuo, H ^a   Zhang, X ^a   Jiang, R ^a   Ji, J ^a   Deng, L ^a   Qian, X ^a   Zhang, F ^a   Sun, B ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; KRT19 PROTEIN; LINC00974; NOTCH RECEPTOR; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER; UNCLASSIFIED DRUG; ANTIGEN CYFRA21.1; CYTOKERATIN 19; LONG UNTRANSLATED RNA; MICRORNA; MIRN642 MICRORNA, HUMAN; SMALL INTERFERING RNA; TUMOR ANTIGEN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; FEMALE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; RECEIVER OPERATING CHARACTERISTIC; STABLE EXPRESSION; UPREGULATION; AGED; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; LIVER CELL; LIVER TUMOR; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AGED; ANIMALS; ANTIGENS, NEOPLASM; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; KERATIN-19; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; RNA, LONG NONCODING; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84927933097     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.518     Document Type: Article

References (35)

1. Shen Q, Fan J, Yang XR, Tan Y, Zhao W, Xu Y et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Lancet Oncol 2012; 13: 817-826.
2. Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y et al. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst 2012; 104: 1808-1814.
3. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011; 147: 358-369.
4. Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell 2013; 152: 1298-1307.
5. Xu D, Yang F, Yuan JH, Zhang L, Bi HS, Zhou CC et al. Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/beta-catenin signaling. Hepatology 2013; 58: 739-751.
6. Takahashi K, Yan I, Haga H, Patel T. Long non-coding RNA in liver diseases. Hepatology 2014; 60: 744-753.
7. Quagliata L, Matter MS, Piscuoglio S, Arabi L, Ruiz C, Procino A et al. Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology 2014; 59: 911-923.
8. Hammerle M, Gutschner T, Uckelmann H, Ozgur S, Fiskin E, Gross M et al. Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1). Hepatology 2013; 58: 1703-1712.
9. Tuck AC, Tollervey D. A transcriptome-wide atlas of RNP composition reveals diverse classes of mRNAs and lncRNAs. Cell 2013; 154: 996-1009.
10. Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell 2013; 154: 26-46.
11. Necsulea A, Soumillon M, Warnefors M, Liechti A, Daish T, Zeller U et al. The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature 2014; 505: 635-640.
12. Jia H, Osak M, Bogu GK, Stanton LW, Johnson R, Lipovich L. Genome-wide computational identification and manual annotation of human long noncoding RNA genes. RNA 2010; 16: 1478-1487.
13. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129: 1311-1323.
14. Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 2008; 14: 723-730.
15. Yin Z, Guan D, Fan Q, Su J, Zheng W, Ma W et al. lncRNA expression signatures in response to enterovirus 71 infection. Biochem Biophys Res Commun 2013; 430: 629-633.
16. Xiang JF, Yin QF, Chen T, Zhang Y, Zhang XO, Wu Z et al. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res 2014; 24: 513-531.
17. Govaere O, Komuta M, Berkers J, Spee B, Janssen C, de Luca F et al. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut 2014; 63: 674-685.
18. Zhang JX, Song W, Chen ZH, Wei JH, Liao YJ, Lei J et al. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol 2013; 14: 1295-1306.
19. Kumarswamy R, Bauters C, Volkmann I, Maury F, Fetisch J, Holzmann A et al. The circulating long non-coding RNA LIPCAR predicts survival in heart failure patients. Circ Res 2014; 114: 1569-1575.
20. Younger ST, Rinn JL. 'Lnc'-ing enhancers to MYC regulation. Cell Res 2014; 24: 643-644.
21. Huang JL, Zheng L, Hu YW, Wang Q. Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. Carcinogenesis 2014; 35: 507-514.
22. Ju JH, Yang W, Lee KM, Oh S, Nam K, Shim S et al. Regulation of cell proliferation and migration by keratin19-induced nuclear import of early growth response-1 in breast cancer cells. Clin Cancer Res 2013; 19: 4335-4346.
23. Kim H, Choi GH, Na DC, Ahn EY, Kim GI, Lee JE et al. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis. Hepatology 2011; 54: 1707-1717.
24. Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 2004; 40: 667-676.
25. Luo J, Zhou H, Wang F, Xia X, Sun Q, Wang R et al. The hepatitis B virus X protein downregulates NF-kappaB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells. Int J Oncol 2013; 42: 1636-1643.
26. Dai Y, Wilson G, Huang B, Peng M, Teng G, Zhang D et al. Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer. Cell Death Dis 2014; 5: e1170.
27. Su BH, Qu J, Song M, Huang XY, Hu XM, Xie J et al. NOTCH1 signaling contributes to cell growth, anti-apoptosis and metastasis in salivary adenoid cystic carcinoma. Oncotarget 2014; 5: 6885-6895.
28. Villanueva A, Alsinet C, Yanger K, Hoshida Y, Zong Y, Toffanin S et al. Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. Gastroenterology 2012; 143: 1660-1669 e1667.
29. Yang H, Fang F, Chang R, Yang L. MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor beta receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology 2013; 58: 205-217.
30. Sun N, Chen Z, Tan F, Zhang B, Yao R, Zhou C et al. Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer. Clin Cancer Res 2013; 19: 5136-5145.
31. Uenishi T, Kubo S, Hirohashi K, Tanaka H, Shuto T, Yamamoto T et al. Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer. Br J Cancer 2003; 88: 1894-1899.
32. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R et al. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 2013; 32: 1616-1625.
33. Tang W, Qin J, Tang J, Zhang H, Zhou Z, Li B et al. Aberrant reduction of MiR-141 increased CD47/CUL3 in Hirschsprung's disease. Cell Physiol Biochem 2013; 32: 1655-1667.
34. Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 2014; 25: 666-681.
35. Liu R, Chen X, Du Y, Yao W, Shen L, Wang C et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 2012; 58: 610-618.